Cosmetic Dentist In Atlanta Offers State-of-the-art Technology For Improved Dental Care

Dr. Thomas Kauffman, Atlanta cosmetic dentist, improves patient care with new technology-Galileos 3-D Cone Beam.

2013-05-12

ATLANTA, GA, May 12, 2013 (Press-News.org) Leading family and cosmetic dentist in Atlanta, Dr. Thomas Kauffman, is pleased to introduce the practice's newest piece of dental technology- the Galileos 3D Cone Beam. The new dental diagnostic system is helping the practice continue bringing patients the most efficient, comfortable and effective dentistry possible.

The new Galileos 3D diagnostic system allows Dr. Kauffman and his team to create a precise 3D image of a patient's entire jaw in a matter of seconds- in significantly less time than traditional x-rays. The Galileo's advanced technology gets patients in and out of the office quickly while allowing the Atlanta cosmetic dentist to diagnose problems more accurately and efficiently.

"Our new Galileos X-ray is proving to be a vital instrument for providing us with an in-depth look at a patient's teeth, mouth and jaw. This lets us easily detect early signs of any dental problems, so that we can treat them before they develop into more serious conditions - which could mean fewer appointments for you in the long run," said Dr. Thomas Kauffman, dentist in Atlanta, GA.

In addition to pursuing technology developments, Dr. Kauffman's educational practice website is a valuable tool that patients can use to communicate with the practice, learn about various dental treatments and conditions and access information about the office. Patients can even conveniently request an appointment online, and new patients can download new patient forms in advance of their first visit. From Atlanta dental implants to same day crowns with CEREC, Dr. Kauffman and his professional staff are highly qualified to handle any dental need for patients of every age.

With a strong commitment to enhancing the patient experience, Dr. Thomas Kauffman, family dentist in Atlanta, has established his practice as a leader in dentistry throughout the Atlanta, GA area. Dr. Kauffman's new dental technology further demonstrates the practice's commitment to staying abreast of the latest dental innovations.

About Dr. Thomas Kauffman, DDS, PC: For the past 38 years, Dr. Thomas Kauffman has been providing his patients with exceptional dental health care. He completed his undergraduate studies at North Central College in Illinois, and then received his DDS from Loyola University in Chicago. Dr. Kauffman's general practice residency was completed in the United States Army Dental Corps, and opened his own private dental practice in 1977-fulfilling his dream. Additionally, Dr. Kauffman firmly believes in continuing education, and is committed to staying abreast of leading, cutting edge dentistry techniques, which are essential for providing patients with the highest quality care possible.

Media Contact:
Dr. Thomas Kauffman
contactus@atlantasedationdentistry.org
133 Peachtree Street N.E. Suite 4050
Atlanta, GA Dental 30303
(404) 524-1981
http://www.atlantasedationdentistry.org/

ELSE PRESS RELEASES FROM THIS DATE:

The New Mighty Pizza Oven, Launching Soon on Kickstarter, Will Let Home Chefs Bake Pro-Quality Pizzas in 3-5 Minutes on Their Backyard Grill

2013-05-12

Why is it so hard to bake professional-quality pizza in a regular home oven? This is the question that has troubled Texas engineer and entrepreneur Bert Touma for years as he enjoyed his hobby of baking pizza at home. Now, he not only has the answer, but is getting ready to bring delicious homemade pizza within everyone's reach with the upcoming launch of the Mighty Pizza Oven he designed. The Mighty Pizza Oven is an affordable stainless steel oven insert that uses a standard gas grill as a powerful heat source. It is designed to replicate the baking conditions inside professional ...

The NEI Awards $2.03 Million Commercialization SBIR Grant to Aciont

2013-05-12

The National Eye Institute (NEI), a division of the National Institutes of Health (NIH), awarded a $2.03 million phase IIB grant to Aciont Inc. to fund the clinical development of a non-invasive, passive diffusion-based treatment for uveitis (referred to as DSP-Visulex-TM). The NEI special emphasis peer review panel that reviewed Aciont's proposal stated, "Overall, this is a novel, exciting approach that has potential to make a broad impact in the clinical ophthalmology field and thus is recommended with a high level of enthusiasm." Aciont's Visulex treatment ...

King Ice Lion Pendant Becomes a Hit with Celebrities

2013-05-12

KingIce.com, an online hip hop jewelry retailer, has garnered national attention with its newest pendant. The piece, named Magnus, features an outline of a lion's face and mane adorned with a slanted crown. The King of the Jungle lion necklace has appeared on BET's 106 & Park, Piers Morgan Live, CONAN, Real Time with Bill Maher, the Late Show with David Letterman, and several online videos. The lion pendant has been seen on various hip hop artists and celebrities. According to a King Ice representative, the company has been pleasantly surprised by the pendant's success. ...

Affordable Roar and Explore Adventure Getaway Offers Trio of Top Experiences

2013-05-12

Columbus is home to the nation's No. 1 zoo and No. 1 science center, making it the perfect place for unforgettable family fun this summer. Just in time for spring and summer travel, Experience Columbus today launched its Roar and Explore Adventure Getaway, featuring both of these top-ranked experiences and packed with family fun. This affordable package allows guests to experience a trio of top Columbus adventures at a surprisingly low cost. Families can book their Roar and Explore Adventure Getaway online at www.ColumbusFamilyFun.com or by calling (888) 795-3709. Starting ...

Extremely low 90-day cardiac device infection rates with TYRX antibacterial envelope use

2013-05-11

Denver, CO (May 11, 2013): Use of TYRX, Inc.'s AIGISRx® Antibacterial Envelope reduced major infection rates by more than 90% in patients undergoing Cardiovascular Implantable Electronic Device (CIED) replacement procedures compared to similar high-risk cohorts, according to the CITADEL & CENTURION clinical study results presented on Saturday at the Late Breaking Clinical Trials session at Heart Rhythm 2013, the Heart Rhythm Society's 34th Annual Scientific Sessions. CITADEL / CENTURION is a prospective, multicenter clinical study to evaluate the major device infection ...

Study shows lower rate of inappropriate shocks in patients with Sorin dual chamber ICD devices

2013-05-11

Denver, Colorado, USA, May 11, 2013 –Sorin Group, (Reuters Code: SORN.MI), a global medical company and a leader in the treatment of cardiovascular diseases, announced findings from the landmark OPTION study1 demonstrating that patients with Sorin dual-chamber implantable cardioverter defibrillators (ICDs) experienced a significantly lower incidence of inappropriate shocks compared with patients with standard single-chamber devices (4.3% vs.10.3%, p=0.015).The study also found that there was no difference in all-cause mortality between the two groups. The OPTION study ...

UCLA stem cell researchers move toward treatment for rare genetic nerve disease

2013-05-11

Led by Dr. Peiyee Lee and Dr. Richard Gatti, researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have used induced pluripotent stem (iPS) cells to advance disease-in-a-dish modeling of a rare genetic disorder, ataxia telangiectasia (A-T). Their discovery shows the positive effects of drugs that may lead to effective new treatments for the neurodegenerative disease. iPS cells are made from patients' skin cells, rather than from embryos, and they can become any type of cells, including brain cells, in the laboratory. ...

Private insurers' Medicare Advantage plans cost Medicare an extra $34.1 billion in 2012

2013-05-11

A study published online today finds that the private insurance companies that participate in Medicare under the Medicare Advantage program and its predecessors have cost the publicly funded program for the elderly and disabled an extra $282.6 billion since 1985, most of it over the past eight years. In 2012 alone, private insurers were overpaid $34.1 billion. That's wasted money that should have been spent on improving patient care, shoring up Medicare's trust fund or reducing the federal deficit, the researchers say. The findings appear in an article published in ...

Cocaine vaccine passes key testing hurdle

2013-05-11

NEW YORK (May 10, 2013) -- Researchers at Weill Cornell Medical College have successfully tested their novel anti-cocaine vaccine in primates, bringing them closer to launching human clinical trials. Their study, published online by the journal Neuropsychopharmacology, used a radiological technique to demonstrate that the anti-cocaine vaccine prevented the drug from reaching the brain and producing a dopamine-induced high. "The vaccine eats up the cocaine in the blood like a little Pac-man before it can reach the brain," says the study's lead investigator, Dr. Ronald ...

Research reveals possible reason for cholesterol-drug side effects

2013-05-11

The U.S. Food and Drug Administration and physicians continue to document that some patients experience fuzzy thinking and memory loss while taking statins, a class of global top-selling cholesterol-lowering drugs. A University of Arizona research team has made a novel discovery in brain cells being treated with statin drugs: unusual swellings within neurons, which the team has termed the "beads-on-a-string" effect. The team is not entirely sure why the beads form, said UA neuroscientist Linda L. Restifo, who leads the investigation. However, the team believes that ...